Dexcom has launched a campaign to improve the understanding and accelerate the adoption of Time in Range (TIR) as the standard of care in diabetes management.
A recent UK survey found that despite its clinical and quality-of-life benefits, most people with insulin-treated diabetes are not using TIR. Defined as the percentage of time spent with glucose levels in target, Time in Range is a powerful metric for modern diabetes management. It makes it easier for people to understand how to improve glycaemic control. While technology exists to help keep track of glycaemic control, many people in the UK must self-fund Dexcom or other CGM sensors, as they are not widely available on the NHS.
Multi-platinum recording artist, actor and philanthropist Nick Jonas, a supporter of the Time in Range campaign commented, “Time in Range is about coming together and giving people with diabetes the tools and resources to help them feel healthier and live the life they want. Having lived with Type 1 diabetes for more than half my lifetime, I know how much better I feel when my glucose levels stay within a set range. It’s time for the diabetes community at large to recognise time in range as one of the most important indicators of optimal diabetes management.”
TIR also helps insulin-treated people with diabetes make informed treatment decisions instead of relying solely on the three-month average that a traditional HbA1C test provides. Find out more about Time in Range and access Dexcom resources HERE.
